Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2025-12-25 @ 12:06 AM
NCT ID:
NCT00149058
Eligibility Criteria:
Inclusion Criteria:
* Male or female \>18 years of age
* Weight between 50 kg and 120 kg
* Suspected of having his/her first-documented STEMI
* Symptoms of ischemia of \>20 min with \< 6h prior to PCI
* Either 1mm ST elevation in at least two contiguous limb leads or \>2mm ST elevation in 2 contiguous chest leads
* Primary PCI to occur within 8h from the onset of symptoms
* Women of childbearing potential must have a negative pregnancy test
Exclusion Criteria:
* Contraindications to MRI scanning
* History or ECG evidence of previous STEMI
* Cardiogenic shock
* NYHA class III-IV heart failure
* LBBB or AF on ECG; 6.Major trauma, major surgery, eye, spinal cord, or brain surgery within the last 3 months
* Significant hepatic disturbance
* Chronic renal impairment (Creatinine \>200µmol/L)
* Stroke or TIA \<6 months
* Pregnancy or breast-feeding
* Dependence on alcohol or other DOA
* Significant psychiatric/neurologic disease that would prevent adherence to the requirements of the protocol
* Significant immunocompromise (including, but not limited to AIDS and immune-suppressive therapy
* Current treatment with human recombinant erythropoietin
* Current hemodialysis or peritoneal dialysis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00149058
Study Brief:
Protocol Section:
NCT00149058